Clinical Trial Update: Hidradenitis Suppurativa Patient Experience With Humira Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing Humira for hidradenitis suppurativa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Hidradenitis Suppurativa | Phase 4 | Status: WITHDRAWN